Management

Ola Holmlund

CEO

CEO since 2018. Bachelor’s degree in business administration.

Born: 1969

Experience: Ola has more than 20 years of experience in international sales and launch of medical technology, pharmaceuticals and other life science products.

Ongoing assignments:

Previous assignments in the last five years:

Owns more than five percent of the shares in:

Holdings in the Company: 370,00 shares.

Charlotta Ekman

Chief Financial Officer

Chief Financial Officer since 2022. Pol.mag and Master in Innovation and entrepreneurship.

Born: 1981

Experience: Charlotta has previous experience from a number of leading positions as CFO and COO at innovative and expansive companies.

Ongoing assignments: Board member of  Addace Consulting AB.

Previous assignments in the last five years: CFO of Acosense AB.

Owns more than five percent of the shares in: Addace Consulting AB.

Holdings in the Company:

Jan Holmbäck

Chief Scientific Officer

Chief Scientific Officer since 2010. Doctoral degree in organic chemistry.

Born: 1957

Experience: Jan is a co-founder of Lipidor and has almost 40 years of experience in drug development, especially in analytical and organic chemistry.

Ongoing assignments: Chairman of the board of the Swedish Society for Nature Conservation in Vaxholm. CEO and board member of SumIT System Aktiebolag.

Previous assignments in the last five years:

Owns more than five percent of the shares in: SumIT System AB and Lipidor AB.

Holdings in the Company: 818,811 shares.

Vibhu Rinwa

Program Manager

Vibhu Rinwa has a Doctoral degree in Pharmaceutical Sciences started working with Lipidor in 2018.

Born: 1986

Experience: Vibhu has been able to acquire a large amount of knowledge in formulation science and gained broad experience in pre-clinical and clinical development. She has worked on drug delivery in different complex dosage form designs for New Chemical Entities and value-added generics.

Ongoing assignments:

Previous assignments in the last five years:

Owns more than five percent of the shares in:

Holdings in the Company: 35,755